Finasteride blocks DHT, the hormone that shrinks follicles
doi: Luz, Y., Calvi, I.P., Marques, I.R., Cruz, S.A., Messias, E., Emanuel, P., Azevedo, H., Cardoso, R., Moura, F.A
The MHRA has previously issued safety communications regarding unlicensed injectable preparations sometimes marketed as 'skinny jabs' or lipotropic injections circulating in the UK market, highlighting risks related to sterility, dosing accuracy, and undisclosed ingredients
Tirzepatide, acting on both GIP and GLP-1 receptors, is effective in reducing weight and controlling glucose, providing superior weight loss effects
Together with other modifications in the peptide sequence, this leads to a tirzepatide half-life of over five days [1, 4]